Major life events trigger change processes in mental health. We examined how depressive symptoms change in conjunction with cancer diagnosis during adulthood and old age, and whether sociodemographic variables, cognitive and health resources, and cancer-specific mortality risks moderate eventrelated reaction and adaptation. Specifically, we applied multiphase growth models to prospective longitudinal data from 2,848 participants (age at diagnosis: M ϭ 69, SD ϭ 9.91; 46% women) in the Health and Retirement Study (HRS) who reported receiving a cancer diagnosis while enrolled in the study. On average, individuals experienced a significant increase in depressive symptoms within 2 years of cancer diagnosis, still-elevated levels 2 years postdiagnosis, and smaller increases in depressive symptoms postdiagnosis relative to the increases observed prediagnosis. Better memory and lower cancer-specific mortality risks were protective against increases in depressive symptoms within 2 years of diagnosis and were associated with reporting fewer depressive symptoms 2 years postdiagnosis. Findings suggest that diagnosis-related changes in depressive symptoms are typically characterized by a multiphase pattern, but tremendous between-person differences also emerged within each phase. Follow-up analyses comparing a matched group (N ϭ 2,272) who did not experience cancer provided an additional layer of evidence supporting our inferences. Results indicate that, on average, people adapt and adjust to the challenges accompanying a cancer diagnosis, and illustrate the utility of using natural experiments such as major life events as a paradigm for studying developmental change processes.
Major life events, such as experiencing a severe illness, are among the "nonnormative" experiences that often substantially shape the development of individuals' mental health and overall functioning (Baltes & Nesselroade, 1979; Birren & Cunningham, 1985; Diener, Lucas, & Scollon, 2006; Gerstorf et al., 2010; Ram, Gerstorf, Fauth, Zarit, & Malmberg, 2010) . For example, receipt of a cancer diagnosis is a central life experience that has profound implications for functioning across cognitive, physical health, and well-being domains (Aspinwall & MacNamara, 2005; Costanzo, Ryff, & Singer, 2009; Coughlin, 2008; Stanton, Revenson, & Tennen, 2007) . In this study, we focus on changes in mental health as processes that unfold in the years prior to, within 2 years of (reaction), and the years subsequently following the incidence of a cancer diagnosis (adaptation). Insights into the mental health changes in relation to pathology-related processes have largely accumulated from studies on disability (Fauth, Gerstorf, Ram, & Malmberg, 2012; Lucas, 2007b; Ormel, Rijsdijk, Sullivan, van Sonderen, & Kempen, 2002; Penninx, Leveille, Ferrucci, van Eijk, & Guralnik, 1999; Verbrugge & Jette, 1994) . In contrast, relatively little is known about whether and how mental health changes as cancer-related processes evolve (for notable exception, see Costanzo et al., 2009 ). Here, we use prospective multiwave longitudinal data from the Health and Retirement Study (HRS) to examine how depressive symptoms change in relation to cancer diagnosis and whether sociodemographics, cognitive and health resources, and cancer-specific mortality risks moderate reaction and adaptation to diagnosis.
Reaction and Adaptation to Cancer Diagnosis
Developmental changes in mental health prompted by nonnormative events may proceed in stages or phases. For example, the hedonic treadmill model of well-being proposes that changes in well-being that accompany major life events proceed in two stages (Brickman & Campbell, 1971; Diener et al., 2006; Frederick & Loewenstein, 1999; Lucas, 2007a) . In a first phase, individuals react to the initial occurrence of the event-this is referred to as reaction. Incidences such as the onset of a chronic illness may provoke decrements in mental health through event-related distress, life disruption, or reorganization of resources (Stanton et al., 2007; Wrosch, Schulz, & Heckhausen, 2004) . In a second phase, when some time has passed after an event (months to years), individuals' mental health may return back to a previous levelthis is referred to as adaptation (Brickman & Campbell, 1971; Diener et al., 2006) . This phase may proceed as individuals draw upon their cognitive, psychosocial, and motivational resources to effectively use adaptive and compensatory strategies to protect against prolonged negative emotional states and declines in overall functioning (Heckhausen, Wrosch, & Schulz, 2010; Lucas, 2007b) . In the cancer literature, the focus is often on how people change and adapt in the months and years following cancer diagnosis. Carver (1998) highlights three forms of adaptation-impairment, resilience, and thriving. Survival with impairment refers to whether participants show sustained lower levels of functioning following cancer diagnosis, resilience is a return to normal or baseline functioning, and thriving is described as exceeding one's original level of functioning (for discussion, see Carver, 1998; Costanzo et al., 2009) .
Research targeting reaction and adaptation processes in mental health with the experience of a cancer diagnosis has used both panel surveys and clinical samples. Typically, reaction to the diagnosis is characterized by a substantial reduction in levels of mental health and well-being. For example, Costanzo and colleagues (2009) used panel survey data from the Midlife in the United States Study (MIDUS) to compare cancer survivors both prior to and 4 years (on average) postdiagnosis with an age-, gender-, and education-matched control group. Cancer survivors were found to experience steeper increases in depressive symptoms than the controls, and differences in other aspects of mental health, such as positive and negative affect, were already discernible prior to diagnosis. In clinical samples diagnosed with breast, lung, or colorectal cancer, researchers found that individuals reported declining quality of life and increasing depressive symptoms within 3 months of cancer diagnosis but observed improvements within 2 years postdiagnosis (Mor, Allen, & Malin, 1994; Schroevers, Ranchor, & Sanderman, 2006) . Similarly, in samples of women with breast cancer, mental health was lowest 3 months postdiagnosis but steadily improved within 2 years postdiagnosis (Heim, Valach, Schaffner, 1997; Hinnen et al., 2008) .
Empirical results about whether or not people are able to adapt to a cancer diagnosis are rather inconsistent. To illustrate, some studies comparing the mental health of cancer survivors with individuals never diagnosed with cancer have found that cancer survivors report long-term poorer mental health (i.e., survival with impairment; Polsky et al., 2005; Rabin et al., 2007) , whereas other studies did not find evidence of prevailing differences in mental health (i.e., resilience; Ganz, Rowland, Desmond, Meyerowitz, & Wyatt, 1998; Helgeson & Tomich, 2005) . Still other studies have followed individuals diagnosed with cancer for several years and suggest that many people indeed adapt to this life-threatening illness. Specifically, participants in clinical samples who reported initial decrements in mental health within 3 months following diagnosis often experienced improvements in quality of life, depressive symptoms, and psychological distress later on, approaching the levels recorded before the diagnosis within 2 years (i.e., resilience; Hinnen et al., 2008; Northouse, Mood, Templin, Mellon, & George, 2000; Schroevers et al., 2006) .
Resilience Factors of Mental Health in the Context of Cancer Diagnosis
Looking beyond the average trends, psychological reaction and adjustment to chronic illnesses is heterogeneous, marked by substantial between-person differences (for review, see Stanton et al., 2007) . To illustrate, for some individuals, major life events are accompanied by massive disruptions in everyday life and mental health, whereas others are resilient and experience little decrements in functioning (Aspinwall & MacNamara, 2005; Bonanno, 2004; Coughlin, 2008; Mancini, Bonanno, & Clark, 2011) . Notions of resilience suggest that individuals who can draw from their psychological and social resources in times of need are less reactive and are better able to adapt to the challenges imposed by those events (see Garmezy, 1991; Rutter, 1987) . Resilience factors may operate by reducing the initial event-related distress and life disruption (reaction); and also reducing negative chain reactions in the years after-thus fostering adaptation. To test such notions, we examined how a variety of resources that individuals might draw upon do indeed moderate reaction and adaptation by promoting resilience and buffering the impact of cancer diagnosis on mental health.
Although chronological age was repeatedly found to contribute to between-person differences in dealing with and adjusting to cancer, the direction of this association is unclear. Some studies report that younger age was associated with steeper mental health declines (Costanzo et al., 2009) , whereas others report that younger individuals showed shallower diagnosis-related declines (Helgeson, Snyder, & Seltman, 2004) . Women may show a shallower event-related response to cancer diagnosis because they are socially more integrated than men and manage to actively seek out and mobilize the available social support in times of strain (Lang, Featherman, & Nesselroade, 1997; Stanton et al., 2007) . Education may also contribute to the heterogeneity in reactions to a cancer diagnosis. Individuals with more education may have access to, and knowledge of, resources and coping strategies that are beneficial in the face of a stressful experience like cancer (Carver, 2005) . Finally, assuming that marital status serves as a proxy for access to social resources or emotional support that can be drawn upon in times of distress, married or partnered individuals can be expected to experience fewer diagnosis-related decrements in mental health compared with single or widowed persons (Helgeson et al., 2004) .
As a unique contribution, our study also examined whether cognitive (memory) and physical (functional limitation) resources, and cancer-specific mortality risks, serve as resilience factors that moderate reaction and adaptation to cancer diagnosis. First, cognitive resources strengthen individuals' abilities to remember, This document is copyrighted by the American Psychological Association or one of its allied publishers.
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plan, and carry out everyday activities such as adhering to medical regimens (Gottfredson & Deary, 2004; Infurna, Gerstorf, Ryan, & Smith, 2011; Reyna, Nelson, Han, & Dieckmann, 2009) . Cognitive resources also foster coping with new stressors that accompany a cancer diagnosis (e.g., organizing physician appointments, medical treatments, and transportation needs; dealing with health insurance company issues ; Insel, Morrow, Brewer, & Figueredo, 2006; Stawski, Almeida, Lachman, Tun, & Rosnick, 2010; Stuck et al., 1999) . Second, physical functioning resources and the ability to complete everyday activities of daily living (e.g., bathing, dressing, or cooking needs) while facing a challenging disease may protect against decrements in mental health. For example, functional limitations prevent people from being actively engaged in social network opportunities and often stand in the way of attaining desired outcomes (Buchman, Wilson, & Bennett, 2008; Infurna, Gerstorf, Ram, Schupp, & Wagner, 2011; Lövdén, Ghisletta, & Lindenberger, 2005) . Finally, cancer-specific mortality risk and survival expectations, along with the associated severity, typical rate of progression, and treatments, may modulate one's mental health. For example, receiving a cancer diagnosis with a very low survival rate can be expected to result in larger mental health declines (increases in psychological distress and depressive symptoms) than receiving a diagnosis with a higher survival rates (e.g., breast cancer, 89% survival rate vs. digestive system, 45% survival rate; Altekruse et al., 2010) , probably because of more aggressive forms of treatment or prospects of diminished survival (Andersen, 1992) .
The Present Study
Our objective in the present article was to examine how developmental changes in depressive symptoms unfold prior to, within 2 years of, and in the years after receiving a cancer diagnosis, and whether sociodemographic factors, cognitive and physical resources, and cancer-specific mortality risks moderate reaction and adaptation to diagnosis. From the literature reviewed here, and along the lines of the hedonic treadmill model (Brickman & Campbell, 1971) , we hypothesize that changes in depressive symptoms that surround a cancer diagnosis will be characterized by a multiphase pattern. For the first phase, we hypothesize that individuals experience significant increases in depressive symptoms within 2 years of cancer diagnosis (reaction). For the second phase, we hypothesize that depressive symptoms in patients will return to prediagnosis levels 2 or more years after diagnosis (adaptation). Finally, it is difficult to predict which form depressive symptom trajectories take on in the adaptation phase. It is possible that many individuals do not (fully) adapt to the cancer diagnosis and experience increases in depressive symptoms that are stronger postdiagnosis than they were prediagnosis. Alternatively, people may, on average, adapt and exhibit levels of and changes in depressive symptoms after the diagnosis that are comparable with those before the diagnosis. Focusing on between-person difference factors that moderate reaction and adaptation, we expect that people who have more cognitive and physical health resources to draw upon (i.e., exhibit better memory and experience fewer functional limitations), as well as those who are diagnosed with a less severe form of cancer are expected to be more resilient, maintaining their mental health and being protected against diagnosis-related increases in depressive symptoms.
We aim to provide substantive insights over and above what is already known regarding how mental health is experienced in relation to cancer diagnosis. First, it is largely an open question whether people who are diagnosed with cancer are already experiencing mental health decrements in the years leading up to diagnosis. In follow-up analyses, we make use of propensity score matching procedures to assess whether onset of cancer diagnosis was foreshadowed by more pronounced increases in depressive symptoms compared with a matched control group with no history of cancer. Second, up to this point, the research is mixed regarding the adaptive capacity of people who experience cancer diagnosis. By having data on participants' mental health on multiple occasions both prior to and after cancer diagnosis, we are able to examine whether participants' levels and rates of changes in mental health are experienced similarly postdiagnosis compared with prediagnosis. Third, as an extension of previous research, we targeted how cognitive and health resources, as well as cancerspecific mortality risks, may moderate depressive symptoms changes with cancer diagnosis and/or promote resilience (Bonanno, Westphal, & Mancini, 2011) .
Methodologically, our study contributes to the literature in two specific ways. First, the prospective nature of the large and nationwide HRS allowed tracking mental health changes (a) during a considerably long period prior to cancer diagnosis, (b) within 2 years of the diagnosis, and (c) for an extended period of time after cancer diagnosis. Making use of conditional growth curve models, we examine within-person longitudinal changes in depressive symptoms and the between-person difference factors that may moderate those changes (for discussions, see McArdle & Nesselroade, 2003; Singer & Willett, 2003) . The flexibility of the growth curve framework allows us to examine multiple phases of change-reaction and adaptation to cancer diagnosis (further discussion in the Method section). Additionally, a novel methodological contribution of our study is the use of propensity score matching methods (for discussion, see Stuart, 2010) to more precisely examine potentially causal effects with observational data. We examined if and how case-matched groups of participants who did and who did not experience cancer diagnosis over the course of the study differed on trajectories of depressive symptoms (across a time-in-study metric). These case-matched control analyses provide some firmer ground from which to evaluate whether diagnosis-related changes in depressive symptoms might result from a number of possible confounds rather than from the diagnosis.
Method

Participants and Procedure
The HRS is a nationally representative probability sample of households in the contiguous United States that consists of noninstitutionalized adults aged 50 years and older (N ϭ 30,000 ϩ individuals; for details, see McArdle, Fisher, Kadlec, 2007; Soldo, Hurd, Rodgers, & Wallace1997) . Participants provide biennial reports on a wide range of economic, sociological, mental, and physical health measures through telephone (for those younger than 80 years of age) or face-to-face (for those 80 years of age and older) interviews, with few differences noted between the two modes of assessment (Herzog & Rodgers, 1988 2 Ͻ .01 for all comparisons) suggest that the study sample is comparable with the study population from which they were drawn. As a consequence, the initial level from which the diagnosis-related trajectories of depressive symptom develop is comparable with the larger population.
1,2
As will be introduced later in the analysis section, we also made use of data from another set of participants (N ϭ 2,272) who were matched to the above sample on T1 age, gender, education, total number of depressive symptoms observations, and depressive symptoms, functional limitations, memory, and self-rated health, but who had not been diagnosed with a cancer at any point prior to, or during, their study enrollment.
Measures
Depressive symptoms. Eight items from the Center for Epidemiologic Studies-Depression (CES-D) scale (Radloff, 1977) were used to assess depressive symptoms. Items asked participants whether they had (ϭ 1) or had not (ϭ 0) experienced the following symptoms "much of the time during the past week": feeling depressed, everything was an effort, restless sleep, was not happy, felt lonely, did not enjoy life, felt sad, and could not get going. The sum across items is taken as an indicator of the number of depressive symptoms an individual experienced frequently. The shorter scale with different response scale (yes or no vs. several response categories ranging from rarely or none of the time to most or all of the time) used in the HRS has demonstrated highly similar construct and external validity as the standard CES-D (see Kohout, Berkman, Evans, & Cornoni-Huntley, 1993; Steffick, 2000) . To facilitate interpretation of relative changes, depressive symptoms were standardized to a T score metric (M ϭ 50, SD ϭ 10) based on the total HRS (N ϭ ϳ30,000) sample's first reports.
Time: Time to and from cancer diagnosis. Cancer diagnosis was assessed at each wave using a single item, "Has a doctor ever told you that you have cancer or a malignant tumor, excluding minor skin cancer?" Onset of cancer diagnosis was defined as the wave of the first interview at which the participant reported being newly diagnosed with cancer. The number of years to and from this point of onset serves as the "time to and from cancer diagnosis" time metric. As shown in Table 1 , realigning the time metric allowed tracking individuals up to 16 years prior to and up to 14 years after cancer diagnosis. On average, participants provided 6.30 (SD ϭ 2.53) of 9 possible biennial reports, 3.69 (SD ϭ 2.15) prior to diagnosis, and 2.62 (SD ϭ 2.04) after diagnosis. Participants were more likely to provide data in the years prior to cancer diagnosis compared with the years following cancer diagnosis. This may be due to people having died or dropping out of the study. Compared with our parent sample, the subsample that did not provide data following cancer diagnosis were ϩ 0.26 SD (where SD refers to that of the parent N ϭ 2,840 sample) on age, Ϫ0.14 SD on education, ϩ0.18 SD on functional limitations, and Ϫ0.17 SD on memory (for discussion, see Lindenberger, Singer, & Baltes, 2002) , suggesting that older age prior to cancer diagnosis, less education, more functional limitations, and poorer memory prior to cancer diagnosis were each associated with decreased likelihood of participation in the study following cancer diagnosis. 1 We note that our subsample of participants who were diagnosed with cancer over the course of the study consisted of a larger proportion of males to females than compared with the larger HRS sample from which our subsample was drawn. In follow-up analyses, we targeted whether men and women exhibited different levels and time-related changes in depressive symptoms in relation to cancer diagnosis. To do so, we ran separate growth curve models for men and women, and found that both men and women experienced time-related increases in depressive symptoms prior to cancer diagnosis and a significant increase in depressive symptoms within 2 years of diagnosis. However, men were more likely to report stillelevated levels of depressive symptoms 2 years postdiagnosis, whereas women, on average, returned back to their prior levels of functioning postdiagnosis and experienced smaller increases in depressive symptoms postdiagnosis.
2 In particular, we ran separate growth curve models for participants who were younger (age at cancer diagnosis Ͻ 70) and older (age at cancer diagnosis Ն 70). Results revealed that younger and older participants alike experienced time-related increases in depressive symptoms prior to cancer diagnosis and a significant increase in depressive symptoms within 2 years of diagnosis. However, we found an age-differential pattern for the adaptation phase, with older adults showing somewhat better adjustment. In particular, results revealed that younger participants were more likely to report still-elevated levels of depressive symptoms 2 years postdiagnosis as well as stronger increases postdiagnosis than those observed prediagnosis. In contrast, older participants, on average, returned back to their prior levels of functioning postdiagnosis and experienced similar rates of change in depressive symptoms postdiagnosis. This may be due to cancer diagnosis being perceived as more of an on-time event for people in older ages, resulting in better adaptation, whereas cancer diagnosis in midlife may be viewed as an "off-time" event, with less anticipation for such challenges that may disrupt one's work and family life (Costanzo et al., 2009; Neugarten & Hagestad, 1976) . Alternatively, it is also possible that this result emerged as a consequence of differential dropout, with older individuals being less likely to survive the cancer. If this scenario were true, the adaptation effect observed among older people would be to a stronger degree contingent upon survival and study participation than it is among younger people. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Our longitudinal models methods assume data are missing at random and thus may be biased in being more generalizable to participants who provided more data following cancer and were healthier or more likely to survive the cancer.
To examine processes of reaction and adaptation to cancer diagnosis, we operationally defined two time-varying variables that would isolate the reaction and adaptation phases of adjustment. Reaction represents the impact within 2 years of diagnosis. An effect-coded diagnosis variable was used to designate the observation within 2 years after the cancer diagnosis (i.e., year 0). The diagnosis variable was coded as 0 for all years prior to cancer diagnosis (years Ϫ16 to Ϫ2); as 1 for the observation within 2 years of the cancer diagnosis (year 0); and as 0 for all the years thereafter (years 2 to 14). Adaptation represents the phase of psychological adjustment following a reaction to cancer diagnosis. An effect-coded postdiagnosis variable was used to designate all the observations (waves) that were obtained after the initial cancer diagnosis observation. Postdiagnosis was coded as 0 for all waves preceding the wave after cancer diagnosis (years Ϫ16 to 0) and as 1 for waves at least 2 years following cancer diagnosis (i.e., years 2 to 14). We use the term "years following a cancer diagnosis" when referring to the 2 to 14 years subsequently following incidence of a cancer diagnosis to refer to the adaptation phase.
Resilience factors. Table 2 shows descriptive statistics for resilience factors that were hypothesized to moderate individuals' reaction and adaptation to diagnosis. With an interest in the resources individuals could draw from, we used the reports obtained at the wave prior to cancer diagnosis. These variables included age, gender, years of education, marital status, memory, and functional limitations. Memory was measured as the proportion of words correctly remembered from both the immediate and delayed free-recall tests (i.e., 20 words in total, with higher scores representing better memory; McArdle et al., 2007) . Functional limitations were measured using a composite sum index of the number of everyday activities participants reported having any difficulty completing, including walking several blocks, climbing one flight of stairs, pushing or pulling large objects, lifting or carrying 10 lb (4.53 kg) of weight, and picking up a dime. Higher scores represent greater functional limitations or poorer physical functioning (Rodgers & Miller, 1997) . Although abbreviated versions of standard activities of daily living (ADL) and instrumental activities of daily living (IADL) questionnaires were used, the HRS's measures of functional limitations are comparable with the standard scales (see Fonda & Herzog, 2004; Rodgers & Miller, 1997) . Gender: Men, n ϭ 1,524; Women, n ϭ 1,324. Marital status: not married/partnered, n ϭ 880; married/partnered, n ϭ 1,968. Categories by cancer-specific mortality risk: below 66%, n ϭ 1,088, 38%; above 66%, n ϭ 1,760, 62%. Categories by 5-year survival: Less than 5 years, n ϭ 563; More than 5 years, n ϭ 2,285. ‫ء‬ p Ͻ .05. This document is copyrighted by the American Psychological Association or one of its allied publishers.
Cancer-specific mortality risk was measured as the 5-year survival rate of participants' primary cancer site. Cancer site (e.g., breast, digestive system) information was provided by the participant at the same time that they reported having received a cancer diagnosis. Using the average all-cancer sites 5-year survival rates reported by the National Cancer Institute and Surveillance Epidemiology and End Results (SEER) (Altekruse et al., 2010) , we divided participants into two groups: those who had cancers that were less risky (survival rate above 66%; n ϭ 1,760) and those who had cancers that were more risky (survival rate below 66%; n ϭ 1,088). Although the participants in our study were diagnosed with cancer at different times between 1994 and 2008, our 5-year survival rate cutoff was based on the most recently available statistics (from 2007). The inference is justified in that the average 5-year survival rate remained in the low to mid-60s range during the study period (see Howlader et al., 2011) . A larger proportion of our sample was diagnosed with cancers that had a more than average 5-year survival rate. We note that substantively similar findings were obtained when we included the primary cancer site 5-year survival rate into our analyses as a continuous variable. For additional specificity, we also included a dummy-coded variable indicating whether a participant was known to have actually died within 5 years of cancer diagnosis (0 ϭ survived 5 years, n ϭ 2,285; 1 ϭ did not survive 5 years, n ϭ 563). It appears conceivable that the 5-year survival rate primarily affects reaction to cancer diagnosis, whereas the objective living conditions and survival outcome primarily affect adaptation. This variable was also included in our models to address the homogeneity assumption of our statistical models. That is, inclusion of this variable alleviates the assumption that adaptation would be experienced similarly for individuals, regardless of their survival status after diagnosis. We note that mortality information was available through 2008. As a consequence, participants diagnosed between 2006 and 2008, and who were still alive in 2008, were included in the "survived 5 years" group.
Statistical Procedures
Multiphase growth model. To examine interindividual differences in the hypothesized reaction/adaptation pattern of change, we used a multiphase growth model (see Ram & Grimm, 2007; Singer & Willett, 2003) . Using the time metrics outlined in the previous section, the model was specified as depressive symptoms ti ϭ ␤ 0i ϩ ␤ 1i (time to and from-cancer diagnosis ti )
ϩ ␤ 4i (time to and from-cancer diagnosis ti x postdiagnosis ti ) ϩ e ti where person i's level of depressive symptoms at time t, depressive symptoms ti , is a function of an individual-specific intercept parameter that represents levels prior to diagnosis, ␤ 0i ; an individualspecific slope parameter, ␤ 1i , that captures rates of linear change prior to diagnosis; an individual-specific parameter, ␤ 2i , that represents the change in depressive symptoms within 2 years of the cancer diagnosis (reaction); an individual-specific parameter, ␤ 3i , that represents whether levels of depressive symptoms differ postdiagnosis, compared with prediagnosis (adaptation); an individual-specific interaction between linear rate of change and adaptation period, ␤ 4i , that examines whether the rate of change in depressive symptoms differs prior to and after diagnosis; and residual error, e ti . Individual-specific intercepts and slopes (␤s from the Level 1 model given in the equation) were modeled as
(i.e., Level 2 model) where ␥ 00 , ␥ 10 , ␥ 20 , ␥ 30 , and ␥ 40 are the sample means and between-person differences, and u 0i , u 1i , u 2i , u 3i , and u 4i are assumed to be normally distributed, correlated with each other, and uncorrelated with the residual errors, e ti .
Subsequently, resilience factors were included as predictors at the between-person level (Level 2). Specifically, sociodemographic, cognitive and health resources, and cancer-specific mortality risks were added as predictors of ␤ 0i , ␤ 2i , and ␤ 3i . Of particular interest was whether these variables were related to individuals' reaction (␤ 2i ) and adaptation (␤ 3i ) to cancer diagnosis.
All models were estimated using SAS 9.2 (PROC MIXED; see Littell, Miliken, Steoup, Wolfinger, & Schabenberger, 2006) , with incomplete data accommodated under missing at random assumptions at the within-person level, and, to retain longitudinal data, missing completely at random at the between-person level (Little & Rubin, 1987) .
Propensity score matching. To alleviate concerns that the observed changes may have been driven by other factors or confounds (e.g., sociodemographics) and further substantiate our inferences, we also examined whether participants in our cancer diagnosis subsample (N ϭ 2,848) differed in their normative, time-related changes in depressive symptoms from a matched group of persons without a history of cancer. To do so, we used 1:1 matching methods (for discussion, see Stuart, 2010) to identify "twin" participants in the larger HRS (N ϭ 26,014) who did not report a cancer diagnosis from 1994 to 2008. First, propensity scores were estimated using a logistic regression incorporating T1 age, gender, education, total number of depressive symptoms observations, and depressive symptoms, functional limitations, memory, and self-rated health as predictors of diagnosis. Second, using a between-groups distance matrix based on the sum of the absolute differences on propensity, individuals in the diagnosis group were caliper-matched with nondiagnosis participants so as to reduce the distance between the two groups. This procedure reduced our sample size to 2,272 participants per group, as some "outlier" participants did not have sufficiently similar matched "twins" in the larger sample who did not have a history of cancer. Compared with the matched participants, the nonmatched participants were ϩ 0.09 SD older (where SD refers to that of the parent N ϭ 2,840 sample), Ϫ0.14 SD on education, ϩ0.03 SD on functional limitations, Ϫ0.06 SD on memory, Ϫ0.03 SD on self-rated health, 0.10 SD on depressive symptoms, and Ϫ0.30 SD on total number of observations provided above or below. This suggests that differences between the groups were rather minimal, with the exception of observation frequencies. As such, comparisons between groups are restrained to the overlapping portions of the This document is copyrighted by the American Psychological Association or one of its allied publishers.
distributions rather than the "fringes" (although, here, the fringes are not particularly far away). Third, we examined group-level differences in trajectories of depressive symptoms. Note that because there is no cancer diagnosis "zero point" for the control group, we modeled changes over time-in-study (rather than time to and from diagnosis) in this analysis.
Results
Reaction and Adaptation to Cancer Diagnosis
In a first step, we checked the relative proportion of betweenand within-person variation in the repeated measures of depressive symptoms. The intraclass correlation was .49, indicating that 49% of the total variance in depressive symptoms was between-person variance and 51% was within-person variance. The data thus appeared to contain both substantial amounts of between-person differences and within-person variation over time.
Results from the multiphase growth model examining how depressive symptoms change in relation to cancer diagnosis are given in Table 3 . Figure 1 presents the model-implied trajectories for a subsample of 100 participants, along with the typical pattern of change. Average changes in depressive symptoms were characterized by time-related linear increases prior to diagnosis (␥ 10 ϭ 0.27 T score units/year), slightly higher than average levels of symptoms at the time of the cancer diagnosis (␥ 00 ϭ 52.21 T score units), and a sizable reaction or increase in symptoms at the occasion within 2 years of cancer diagnosis (␥ 20 ϭ 1.38 T score units). Following cancer diagnosis, the typical pattern of change was characterized by slightly elevated levels of depressive symptoms compared with prediagnosis levels (␥ 30 ϭ 0.56 T score units). That is, on average, levels of depressive symptoms reported several years after the diagnosis were lower than within 2 years of the diagnosis but were still higher than before the diagnosis. This suggests that there was some adaptation, but that the adaptation was partial rather than complete. Finally, the typical long-term trajectory was characterized by smaller increases in depressive symptoms after diagnosis (␥ 10 ϩ ␥ 40 ϭ 0.27 Ϫ 0.18 ϭ 0.09 T score units/year) than before the diagnosis (␥ 10 ϭ 0.27). Based on the model parameters, we also calculated the cumulative distribution function of the implied normally distributed interindividual differences in depressive symptoms and rates of change. The placement of the distribution suggests that 73% of participants were likely to experience an increase in depressive symptoms in the years preceding cancer diagnosis, and 59% of participants were likely to experience some increase or boost in depressive symptoms with cancer diagnosis. Quantifying the proportion of explained within-person variance using ⌬pseudo-R 2 ϭ 1 Ϫ ( e(c) 2 / e(u) 2 ) (see Snijders & Bosker, 1999) , we found that linear change, reaction, and adaptation effects accounted for 19% of the explainable variance in depressive symptoms (i.e., 1 Ϫ [50.00/62.05]).
As a follow-up analysis to our observation that depressive symptoms increased in the years prior to diagnosis, we examined whether participants in our subsample who were diagnosed with cancer over the course of the study differed in their normative, time-related changes in depressive symptoms to a group of persons without a history of cancer. Results are shown in Table 4 . We observed that depressive symptoms were relatively stable over This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
time in the study (Ϫ.01 SD per 10 years). Participants who reported a new cancer diagnosis did not differ from matched participants who did not experience cancer diagnosis on initial level of depressive symptoms (␥ 01 ϭ 0.34 T score units, p Ͼ .05). However, the cancer diagnosis group did exhibit a time-related increase in depressive symptoms (␥ 10 ϩ ␥ 11 ϭ Ϫ.01 ϩ 0.10 ϭ 0.09 T score units, p Ͻ .05), whereas the group with a diagnosis of no cancer did not (␥ 10 ϭ Ϫ.01, p Ͼ .05). Our analyses suggest that cancer diagnosis does contribute to changes in depressive symptoms.
Resilience Factors of Mental Health in the Context of Cancer Diagnosis
With the variance components suggesting that there were meaningful between-person differences in both extent of reaction ( u2 2 ϭ 34.95, p Ͻ .01) and adaptation ( u3 2 ϭ 18.01, p Ͻ .01) to cancer diagnosis, we proceeded to examine whether sociodemographic, cognitive and health resources, and cancer-specific mortality risks moderated those differences. Results from the expanded model are shown in Table 5 . We found that participants who were older (␥ 01 ϭ Ϫ0.08, p Ͻ .01), attained more years of education (␥ 03 ϭ Ϫ0.51, p Ͻ .01), were married/partnered (␥ 04 ϭ Ϫ3.16, p Ͻ .01), and exhibited better memory (␥ 05 ϭ Ϫ3.05, p Ͻ .01) and fewer functional limitations (␥ 06 ϭ 2.10, p Ͻ .01) were more likely to experience fewer depressive symptoms prior to cancer diagnosis. Most pertinent to our research question, our results show that cancer-specific mortality risk (␥ 27 ϭ 0.92, p Ͻ .05), marital status (␥ 24 ϭ 1.93, p Ͻ .01), and, to a lesser extent, memory (␥ 25 ϭ Ϫ2.21, p ϭ .08) moderated reaction to cancer diagnosis. Individuals who were diagnosed with a cancer that had a lower 5-year cancer-specific mortality risk (i.e., greater than 66% survival rate over 5 years), were not married or partnered, and exhibited better memory experienced a less steep increase in depressive symptoms within 2 years of cancer diagnosis. Additionally, we observed that marital status (␥ 34 ϭ 1.44, p Ͻ .01), memory (␥ 35 ϭ Ϫ4.23, p Ͻ .01), and cancer-specific mortality risk (␥ 37 ϭ 1.31, p Ͻ .01) each moderated adaptation. That is, individuals who were diagnosed with a cancer that had a lower 5-year cancer-specific mortality risk, were not married or partnered, and had performed better on memory were more likely to report fewer depressive symptoms 2 years after cancer diagnosis. Figure 2 illustrates how cancer-specific mortality risk and cognitive resources moderated reaction and adaptation to cancer diagnosis (model-implied trajectories for a subsample of 100 participants are graphed). Panel A shows that participants diagnosed with a less severe cancer (lower cancer-specific mortality risk) experienced smaller increases in depressive symptoms within 2 years of diagnosis and lower levels thereafter compared with those who were diagnosed with a more severe cancer (higher cancerspecific mortality risk). Panel B illustrates that participants with better memory prior to diagnosis (ϩ1 SD) were somewhat protected against increases in depressive symptoms within 2 years of and in the years after cancer diagnosis relative to those with poor memory (Ϫ1 SD). Finally, the bottom portion of Table 5 shows that the variance components for reaction and adaptation were still significant ( u2 2 and u3 2 ), suggesting that the resilience factors we included in our models did not account for all of the betweenperson differences. It is likely that further personal and social resources not measured in the HRS also play a vital role in psychological adjustment to cancer diagnosis. Model implied means for depressive symptoms in relation to cancer diagnosis and predicted scores for a subsample of 100 participants (thin gray lines). Changes in depressive symptoms are characterized by a multiphase pattern (thick black line). HRS participants typically reported a significant increase in depressive symptoms within 2 years of cancer diagnosis, followed by elevated levels after diagnosis. Changes in depressive symptoms were less steep after cancer diagnosis than prior to diagnosis.
This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Discussion
Using multiwave prospective panel data from the HRS, we observed that developmental changes in depressive symptoms with a cancer diagnosis were characterized by a multiphase pattern. As a reaction to the diagnosis, depressive symptoms typically increased. Several years after the diagnosis, depressive symptoms had declined but were still higher than before the diagnosis-a pattern one can interpret as partial adaptation. Further evidence of adaptation was found several years after the diagnosis, with individuals typically reporting smaller increases in depressive symptoms than before the diagnosis. We also found heterogeneity in how participants' mental health reacted and adapted to cancer diagnosis. Cognitive resources and lower cancer-specific mortality risks were each protective of diagnosis-related increases in depressive symptoms and were associated with better adaptation or lower levels after diagnosis. Our prospective longitudinal data derived from a nationwide sample of older Note. N ϭ 2,848. Number of observations ϭ 17,952. Age, marital status, memory, and functional limitations measurements were taken from the observation prior to cancer diagnosis. LL ϭ Log-Likelihood; SE ϭ standard error. ‫ء‬ p Ͻ .05. This document is copyrighted by the American Psychological Association or one of its allied publishers.
adults allowed us to track how mental health changes, as processes underlying cancer diagnosis, unfold in the years prior to, within 2 years of, and in the years following diagnosis. Our discussion focuses on changes in mental health in the context of cancer, resilience factors that contribute to psychological adjustment, and the utility of using natural experiments, such as major life events, for studying developmental change processes.
Reaction and Adaptation to Cancer Diagnosis
In contrast to previous empirical reports that show mental health is relatively stable across adulthood and old age (see Charles, Reynolds, & Gatz, 2001; Griffin, Mroczek, & Spiro, 2006; Kunzmann, 2008) , we observed that depressive symptoms were, on average, already increasing in the years prior to the cancer diagnosis. To examine this further, we used propensity score matching procedures to identify a group of "control" participants who never received a cancer diagnosis. Testing for differences, we found that the cancer diagnosis group had steeper time-related increases in depressive symptoms than peers without a cancer diagnosis. These results suggest that the cancer diagnosis may (causally) contribute to changes in depressive symptoms. An evolving pathology may accumulate and exert its effects on mental health before clinical levels are reached and a diagnosis is received. It is in this sense that time-related increases in depressive symptoms may foreshadow an eventual cancer diagnosis (Lutgendorf, Costanzo, & Siegel, 2007; Spiegel & Giese-Davis, 2003) . We note that these assertions are highly speculative. One possibility to thoroughly test this notion would be to contrast different cancers and/or stages with one another, with the assumption that the increase in depressive symptoms before the diagnosis would be steeper if the cancer was not diagnosed until a late stage and thus had more time to evolve and exert influence on function. Our findings shed light on how persons may experience differential rates of change in mental health (or other areas of functioning) depending on the developmental process that is being studied.
In accordance with the hedonic treadmill model of well-being, we observed that mental health changes in relation to cancer diagnosis proceeded in distinct stages (see Table 3 ). Similar to previous research examining mental health changes with disability and widowhood (Fauth et al., 2012; Lucas, 2007a; Ong, FullerRowell, & Bonanno, 2010) , the typical individual experienced an increase in depressive symptoms (or decrements in mental health) within 2 years of the diagnosis, followed by sustained, somewhat Figure 2 . Graphical illustration of the protective effect of cancer-specific mortality risk and memory on depressive symptoms. Model-implied trajectories are shown for a subsample of 100 participants (thin gray lines). Panel A shows that participants diagnosed with a less severe cancer (lower cancer-specific mortality risk; solid line) experienced smaller increases in depressive symptoms within 2 years of diagnosis and lower levels thereafter compared with those who were diagnosed with a more severe cancer (higher cancer-specific mortality risk; dashed line). Panel B illustrates that participants with better memory prior to diagnosis (ϩ1 SD) were somewhat protected against increases in depressive symptoms within 2 years of, and in the years after, cancer diagnosis (solid line) relative to those with poor memory (Ϫ1 SD; dashed line). This document is copyrighted by the American Psychological Association or one of its allied publishers.
elevated levels of depressive symptoms 2 to 4 years following diagnosis. Our findings are similar to and replicate previous studies showing that mental health decreases when diagnosed with cancer (Costanzo et al., 2009; Polsky et al., 2005) . Previous work has already shown the effectiveness of psychosocial interventions for cancer patients that improve well-being, reduce rates of recurrence, and provide for higher survival rates (Fawzy et al., 1993; Graves, 2003; Jacobsen et al., 2002; Spiegel, Bloom, Kraemer, & Gottheil, 1989) . Our findings highlight the potential importance of timing such interventions so as to foster mental health during the reaction phase within 2 years of the diagnosis.
As an extension of previous research, our approach of applying multiphase growth curve models to prospective longitudinal data allowed for highlighting that trajectories of mental health were altered due to cancer diagnosis. Following cancer diagnosis, depressive symptoms declined but were still higher than before diagnosis, and participants typically reported smaller increases in depressive symptoms than before diagnosis, indicating partial adaptation. Changes in depressive symptoms after cancer diagnosis approached similar levels to population levels in our case-matched control group, suggesting that people are able to self-regulate and adjust to a cancer diagnosis. Adaptation to cancer diagnosis is similar to previous research focusing on mental health changes in relation to widowhood but in contrast to events where adaptation typically does not occur, such as disability and unemployment (Diener et al., 2006; Lucas, 2007a) . In line with theoretical models in the cancer literature, the partial adaptation we found can be interpreted as an indication of resilience (a la Carver, 1998) . However, with the random effects for reaction, adaptation, and postdiagnosis change all being reliably different from zero, there are substantial between-person differences in the individual manifestations and extent of resilience. Although we modeled differences in change in a continuous manner, it would be instructive for future studies to specifically identify and model subgroups that follow the specific impairment, resilience, and thriving trajectories outlined by Carver (1998) , and examine if and how between-person difference factors predict membership in those trajectory groups.
Our findings of partial adaptation are in slight contrast to previous reports involving clinical samples, which showed that after a decline in mental health in reaction to diagnosis, individuals were able to psychologically adapt and show improvements in mental health 12 to 15 months after diagnosis (Hinnen et al., 2008; Mor et al., 1994) . Cancer diagnosis may result in an altered future time perspective; postdiagnosis individuals are often more focused on emotion-related goals, resulting in better emotion regulation (Carstensen, 2006) . For example, research from Pinquart and colleagues (2007) suggests that with initial diagnosis, cancer patients are likely to truncate their future time perspective. Over time, however, people often revert back to their previous outlook when their prognosis improves. We did not have the data to test such speculation, but future work will be instructive that explores mechanisms mediating adaptation processes.
Resilience Factors of Mental Health in the Context of Cancer Diagnosis
We also examined whether sociodemographic, cognitive and health resources, and cancer-specific mortality risks moderated reaction and adaptation to a cancer diagnosis. Consistent with earlier conceptual work and empirical reports, we found substantial heterogeneity in how individuals' depressive symptoms changed in relation to cancer diagnosis (Bonanno, 2004; Helgeson et al., 2004; Stanton et al., 2007) . We observed that marital status, memory, and cancer-specific risk may serve as resources or constraints that individuals bring to major life events (cancer diagnosis) that moderate one's reaction and adaptation.
We found that individuals who were not married or partnered experienced smaller increases in depressive symptoms within 2 years of cancer diagnosis than those with a close other, and also reported fewer symptoms after diagnosis. This counterintuitive result was in contrast to our expectation that social resources buffer the impact of negative life events on mental health (Bonanno, Galea, Bucciarelli, & Vlahov, 2007) . For people who are married, stronger decrements in mental health may arise from a number of family-related worries and changes in family life (see Couper et al., 2006; Northouse et al., 2000) . For example, partnered individuals may worry to a greater extent about how the disease and potential consequences, such as incapacity or a restricted future time perspective, affects their kinship. Similarly, a more pronounced reaction may also emerge from the emotional and instrumental challenges that dealing with the situation impose upon family life, such as changes in social roles or family functioning. Differences between our findings and other reports may be due to our measure indicating only whether a participant was married or partnered. We had no information available on other crucial social resources that people often draw from in times of need, such as the quality of social relationships, satisfaction with the marriage, and perceiving that the support received was indeed asked for, helpful, and appropriate (Newsom, Rook, Nishishiba, Sorkin, & Mahan, 2005 : Smith & Goodnow, 1999 . Further, in this sample, participants who were not married or partnered had more depressive symptoms at study outset and so probably had less room for further increases. We also found that cognitive resources buffered increases in depressive symptoms within 2 years following diagnosis and were linked to the extent of adaptation after diagnosis. This finding is consistent with the view that cognitive functioning serves as a general-purpose mechanism for adaptation and a resource that people can draw upon in the face of obstacles (Baltes, Lindenberger, & Staudinger, 2006) . Preserved memory provides individuals with cognitive resources-such as knowledge of adaptive and compensatory strategies-that can be used as a cushion against the negative impact of cancer diagnosis and to enhance emotion regulation (Stuck et al., 1999; Willis et al., 2006) . For example, people with better cognitive functioning may have increased mental resiliency for coping with stressors (Lutgendorf & Sood, 2011; Stawski et al., 2010) that arise from (dealing with) the cancer diagnosis (Costanzo, Stawski, Ryff, Coe, & Almeida, 2012) and are better able to adhere to medical regimens such as complex medication schedules (Reyna et al., 2009 ). In addition, cognitive resources are linked to better physical functioning (Gottfredson & Deary, 2004; Infurna, Gerstorf, Ryan, et al., 2011) , and preserved memory, combined with fewer physical health burdens, may help people cope with a cancer diagnosis and buffer mental health decrements.
Finally, our results indicated that individuals who were diagnosed with more risky cancers experienced steeper increases in depressive symptoms within 2 years of diagnosis and sustained elevated levels thereafter. Differences in reaction and adaptation to cancer diagnosis by cancer-specific mortality risk may be due to This document is copyrighted by the American Psychological Association or one of its allied publishers.
the typical rate of progression of the cancer, treatment options, and resources and information available on the particular type of cancer. However, we note that cancer-specific mortality rates may only serve as a proxy for, and are not as accurate as, data on cancer stage and cancer-related mortality assessed through medical records. We did not have access to such information and therefore could not test such speculation, especially to disentangle whether there are possible gender differences due to treatment-related differences. As shown in the Appendix, cancers with a higher survival rate occur more frequently in the population. Therefore, the chances of spotting the cancer in early stages are better, which, in turn, allows for applying treatment options early on, thereby increasing chances of survival. As the search for well-being policy broadens, our findings provide insights into pinpointing betweenperson difference factors associated with larger decrements in mental health with cancer diagnosis. Interventions and societal resources aimed at mitigating the negative impact of cancer diagnosis on depressive symptoms appear most needed when people have fewer cognitive resources to draw upon and when the specific cancer diagnosis is associated with low survival probabilities (Rae et al., 2010; Rowan, Davidson, Campbell, Dobrez, & MacLean, 2002) .
Examining Developmental Change in Relation to Nonnormative Events
It has long been acknowledged that developmental change in crucial domains such as mental health is shaped not only by normative age-graded or history-graded systems of influence but also by nonnormative factors, including the experience of severe medical diseases such as cancer (Baltes & Nesselroade, 1979) . As a consequence, realigning within-person change along such a given experience or diagnosis event may shed additional light on the phenomenon under study and generate insights that cannot easily be gained from a more traditional age-based perspective Infurna, Gerstorf, & Zarit, in press; . For example, our approach of examining mental health changes in relation to cancer diagnosis provided a more parsimonious fit to the data than did chronological age (proportion of explained within-person variance: time to and from cancer diagnosis ϭ .194 vs. chronological age ϭ .107). In a similar vein, examining developmental change processes in relation to major life events permits targeting the "stressful" times when individual's reactive and regulatory systems are in action, the times when interindividual differences in how those systems are functioning will stand out in bas-relief. As such, natural events provide unique opportunities to study the mechanisms underlying successful development Rutter, 2007) .
Our methodological approach of applying growth curve models to multiwave longitudinal data aligned along a "time to and from event" metric enabled us to examine individuals' reaction and adaptation to events. We made use of a natural experiment to better understand the mental health changes accompanying the cancer experience. A logical extension of the approach would be to examine how the trajectories of change differ among specific patient groups. Our large sample included participants who experienced many different types of cancer diagnoses. Employing multigroup methods in future reports may allow identifying distinct subgroups with similarities and differences in how depressive symptoms change prior to and after diagnosis of different types of cancer (e.g., prostate cancer vs. breast cancer). Broadening the application of the approach, it will be useful for exploring event-or diagnosis-related changes in other domains, including cognitive and physical health domains (e.g., Infurna et al., in press; Small et al., 2011) or how those changes affect family members such as spouses or children (Hinnen et al., 2008) . Similarly, extending the model to incorporate multiple variables simultaneously, the approach might inform if and how various domains are coupled or become decoupled by the event. For example, does cancer diagnosis only affect mental health or does it also affect cognitive and physical function? And are the links among these multiple domains compromised or strengthened by the event? Such routes of inquiry would provide insights into how multiple domains and systemic functioning are affected by nonnormative and pathology-related processes (regime switching; see Chow, Zu, Shifren, & Zhang, 2011) . Finally, across fields, propensity score matching methods are being incorporated into inquiries about change. We used these methods to identify a control group who never experienced the event and to rule out a potential alternative explanation of our findings. By equating as closely as possible the sample of people who received a cancer diagnosis to a group of controls who did not, based on a number of possible confounds (e.g., sociodemographic characteristics, levels of depressive symptoms before the event occurred), these analysis provide another layer of evidence supporting (though still tentative) causal inferences about how cancer diagnosis is related to changes in depressive symptoms (Foster, 2010) . As we step further into using these methods, we see that they shall provide new layers of evidence that can better support our still tentative inferences about how nonnormative events induce developmental change.
Limitations and Conclusion
In closing, we note several limitations in our study. First, some of the very strengths of using archival data are also weaknesses, among other things, because the HRS was not initially designed for testing of the specific questions we pursued in this project. As a consequence, crucial information about the cancer, such as stage of cancer, or subjective sense of risk was not available. In future, more mechanism-oriented studies, it will be highly informative to examine whether or not these factors provide additional information about cancerrelated change in depressive symptoms. Similarly, we acknowledge that there are a myriad of potential moderators of change, such as self-reported personal and social resources and objective medical reports, which were not available and were not included in our models. For example, previous work has shown that individuals with higher levels of personal control, selfesteem, and social support and in earlier stages of the cancer progression (e.g., Stage 1 vs. Stage 3) report more favorable psychological adjustment following cancer diagnosis (Heim et al., 1997; Helgeson et al., 2004; Stanton et al., 2007) . Second, assessments in the HRS are taken biennially and cancer diagnosis could have occurred anywhere from a month to almost 2 years prior to the wave in which participants first reported being This document is copyrighted by the American Psychological Association or one of its allied publishers.
diagnosed with cancer. This might bias the data toward the less severe cancers, as the persons with more advanced and severe cancers could have died within the 2-year period. More closely spaced assessment intervals would certainly be better suited to capturing the nuances of reaction and adaptation processes, as well as tracking longer-term changes more precisely (e.g., nonlinear trends). Third, the benefits of a rich longitudinal dataset are tempered by a lack of precision in how some of the variables that were examined here were measured; because individuals may have been diagnosed at any time in between assessment intervals, the "time to and from diagnosis" metric contains some error of measurement. Although past research on other critical life events, such as disability, has dealt with the problem in a similar fashion (see Fauth et al., 2012; Ferrucci et al., 1996; Lucas, 2007b) , caution is warranted. We also note that the resulting misalignment serves to confound changes occurring directly after the onset of cancer diagnosis with those that occurred some months or years later. For example, people within 2 years of cancer diagnosis are potentially at very different points along the trajectories of both reaction and adaptation to the diagnosis and progression of the disease. Fourth, results from our multilevel models of change revealed that there is substantial heterogeneity in levels and rates of change in depressive symptoms. The noted patterns of change may be driven or confounded (depending on perspective) by particular subgroups who are resilient and recover quickly or who experience chronic levels of depressive symptoms following cancer diagnosis (e.g., Bonanno, 2004; Helgeson et al., 2004; Hou, Law, Yin, & Fu, 2010; Mancini et al., 2011) . Further work is warranted to distinguish and study how observed or unobserved groups within the population may react and adapt to cancer diagnosis. Finally, we used propensity score matching methods to examine whether persons diagnosed with cancer experienced stronger normative, time-related changes in depressive symptoms. To do so, we had to change the time metric from "time to and from cancer diagnosis" to "time in study." Future research should target the timing of a nonevent compared with an event occurring (e.g., match groups on circumstances with elevated risks for an event). In addition, variables the groups were not matched on will also certainly contribute to the remaining heterogeneity of the groups (Winship & Morgan, 1999) , and as shown in our study, we were not able to match each of our participants who experienced cancer diagnosis to someone from the larger HRS who had no history of cancer. In sum, experiencing a cancer diagnosis challenges the selfregulation system and results in a reduction of mental health (reaction). After this initial life disruption and distress, people appear to become more and more able to meet the challenges and issues that arise from cancer incidence and regain some of the losses (partial adaptation). In contrast to previous research primarily using postdiagnosis levels and rates of change, our methodological approach applied to prospective longitudinal data was critical in identifying the multiphase pattern we observed. Our findings carry some weight in describing reaction and adaptation to cancer in the general population because our participants were identified prospectively from a larger nationwide sample of people 50 years and above in the United States (minimal selection bias). Our findings add to the growing body of literature examining mental health in the context of a cancer diagnosis (Costanzo et al., 2009; Helgeson et al., 2004; Stanton et al., 2007) and, more broadly, how nonnormative influences impact developmental change (Baltes & Nesselroade, 1979; Diener et al., 2006; . We take our results to provide further impetus for examining how mental health and other domains of functioning change with nonnormative experiences and for identifying resilience factors that moderate reaction and adaptation to those processes.
